Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320.
Antonini A, Poewe W (2007) Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. Lancet Neurol 6:826-829.
Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT and 5-HT2 receptors. Neuropsychopharmacology 26:40-52.
Barbano MF, Cador M (2007) Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology (Berl) 191:497-506.
Barbano MF, Le Saux M, Cador M (2009) Involvement of dopamine and opioids in the motivation to eat: influence of palatability, homeostatic state, and behavioral paradigms. Psychopharmacology (Berl) 203:475-487.
B arnes NM, S harp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
Bickerdike MJ (2003) 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Curr Top Med Chem 3:885-897.
Blundell JE, Rogers PJ, Hill AJ (1985) Behavioral structure and mechanisms of anorexia: calibration of natural and abnormal inhibition of eating. Brain Res Bull 15:371-376.
Bonhaus DW, Weinhardt KK, Taylor M, et al (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621-629.
Borgland SL, Taha SA, Sarti F, et al (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601.
Bubar MJ, Cunningham KA (2006) Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971-1985.
Bubar MJ, Cunningham KA (2007) Distribution of serotonin 5-HT2C receptors in the ventral teg-mental area. Neuroscience 146:286-297.
Bubar MJ, Seitz PK, Thomas ML, et al (2005) Validation of a selective serotonin 5-HT2C receptor antibody for utilization in fluorescence immunohistochemistry studies. Brain Res 1063:105-113.
Burbassi S, Cervo L (2008) Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats. Psychopharmacology (Berl) 196:15-27.
Burmeister JJ, Lungren EM, Kirschner KF, et al (2004) Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 29:660-668.
Burns CM, Chu H, Rueter SM, et al (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387:303-308.
Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218.
Callahan PM, Cunningham KA (1995) Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J Pharmacol Exp Ther 274:1414-1424.
Callahan PM, Appel JB, Cunningham KA (1991) Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology (Berl) 103:50-55.
Carlezon WA, Jr., Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-2995.
Carroll ME, Lac ST, Asencio M, et al (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35:237-244.
Childress AR, Hole AV, Ehrman RN, et al (1993) Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 137:73-95.
Clarke PB, Fu DS, Jakubovic A, et al (1988) Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 246:701-708.
Clifton PG, Lee MD, Dourish CT (2000) Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat. Psychopharmacology (Berl) 152:256-267.
Cornelius JR, Perkins KA, Salloum IM, et al (1999) Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients. J Clin Psychopharmacol 19:183-184.
Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284.
Counotte DS, Spijker S, Van de Burgwal LH, et al (2009) Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology 34:299-306.
Covey LS, Glassman AH, Stetner F, et al (2002) A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry 159:1731-1737.
Crombag HS, Grimm JW, Shaham Y (2002) Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology 27:1006-1015.
Crombag HS, Bossert JM, Koya E, et al (2008) Review. Context-induced relapse to drug seeking: a review. Philos Trans R Soc Lond B Biol Sci 363:3233-3243.
Currie PJ, Coscina DV (1997) Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding. Neuroreport 8:3759-3762.
Dalley JW, Laane K, Pena Y, et al (2005) Attentional and motivational deficits in rats withdrawn from intravenous self-administration of cocaine or heroin. Psychopharmacology (Berl) 182:579-587.
Dalley JW, Theobald DE, Berry D, et al (2005) Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology 30:525-537.
Dalley JW, Mar AC, Economidou D, et al (2008) Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav 90:250-260.
Dalton GL, Lee MD, Kennett GA, et al (2006) Serotonin 1B and 2C receptor interactions in the modulation of feeding behavior in the mouse. Psychopharmacology (Berl) 185:45-57.
Deakin JF (1998) The role of serotonin in panic, anxiety and depression. Int Clin Psychopharmacol 13(suppl 4):S1-S5.
Di Chiara G (2000) Role of dopamine in the behavioral actions of nicotine related to addiction. Eur J Pharmacol 393:295-314.
Di Giovanni G, De Deurwaerdere P, Di Mascio M, et al (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587-597.
Di Giovanni G, Di Matteo V, Di Mascio M, et al (2000) Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35:53-61.
Di Giovanni G, Di Matteo V, La Grutta V, et al (2001) m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:111-116.
Di Giovanni G, Di Matteo V, Pierucci M, et al (2008) Serotonin-dopamine interaction: electrophysiological evidence. Prog Brain Res 172:45-71.
Di Matteo V, Di Giovanni G, Di Mascio M, et al (1998) Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology 37:265-272.
Di Matteo V, Di Giovanni G, Di Mascio M, et al (1999) SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195-1205.
Di Matteo V, Di Giovanni G, Di Mascio M, et al (2000) Biochemical and electrophysiological evidence that Ro 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors. Brain Res 865:85-90.
Di Matteo V, Pierucci M, Esposito E (2004) Selective stimulation of serotonin2C receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418-429.
Di Matteo V, Pierucci M, Di Giovanni G, et al (2007) The neurobiological bases for the pharma-cotherapy of nicotine addiction. Curr Pharm Des 13:1269-1284.
Di Matteo V, Di Giovanni G, Pierucci M, et al (2008) Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Prog Brain Res 172:7-44.
Diergaarde L, Pattij T, Poortvliet I, et al (2008) Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 63:301-308.
Doran N, Spring B, McChargue D, et al (2004) Impulsivity and smoking relapse. Nicotine Tob Res 6:641-647.
Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) 86:197-204.
Dray A, Davies J, Oakley NR, et al (1978) The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioral observations. Brain Res 151:431-442.
Epstein DH, Preston KL, Stewart J, et al (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 189:1-16.
Evenden JL (1999) Varieties of impulsivity. Psychopharmacology (Berl) 146:348-361.
Filip M, Cunningham KA (2002) Serotonin 5-HT2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 71:745-756.
Filip M, Cunningham KA (2003) Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin2C (5-HT2C) receptors in rat prefrontal cortex. J Pharmacol Exp Ther 306:734-743.
Filip M, Bubar MJ, Cunningham KA (2004) Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246-1254.
Fitzgerald LW, Iyer G, Conklin DS, et al (1999) Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21:82S-90S.
Fitzgerald LW, Burn TC, Brown BS, et al (2000) Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57:75-81.
Fletcher PJ (1988) Increased food intake in satiated rats induced by the 5-HT antagonists methy-sergide, metergoline and ritanserin. Psychopharmacology (Berl) 96:237-242.
Fletcher PJ (1995) Effects of combined or separate 5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20s schedule of food reinforcement. Brain Res 675:45-54.
Fletcher PJ, Currie PJ, Chambers JW, et al (1993) Radiofrequency lesions of the PVN fail to modify the effects of serotonergic drugs on food intake. Brain Res 630:1-9.
Fletcher PJ, Korth KM, Chambers JW (1999) Depletion of brain serotonin does not alter d-amphetamine self-administration under a variety of schedule and access conditions. Psychopharmacology (Berl) 146:185-193.
Fletcher PJ, Grottick AJ, Higgins GA (2002) Differential effects of the 5-HT2A receptor antagonist M100907 and the 5-HT2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576-586.
Fletcher PJ, Chintoh AF, Sinyard J, et al (2004) Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29:308-318.
Fletcher PJ, Sinyard J, Higgins GA (2006) The effects of the 5-HT2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology (Berl) 187:515-525.
Fletcher PJ, Tampakeras M, Sinyard J, et al (2007) Opposing effects of 5-HT2A and 5-HT2C receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) 195:223-234.
Fletcher PJ, Rizos Z, Sinyard J, et al (2008) The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33:1402-1412.
Fletcher PJ, Le AD, Higgins GA (2008) Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog Brain Res 172:361-383.
Fletcher PJ, Tampakeras M, Sinyard J, et al (2009) Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behavior in 5-HT2C receptor knockout mice. Neuropharmacology 57:259-267.
Fulton S, Woodside B, Shizgal P (2000) Modulation of brain reward circuitry by leptin. Science 287:125-128.
Geyer MA, Vollenweider FX (2008) Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 29:445-453.
Gobert A, Rivet JM, Lejeune F, et al (2000) Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205-221.
Gray RW, Cooper SJ (1996) D-fenfluramine's effects on normal ingestion assessed with taste reactivity measures. Physiol Behav 59:1129-1135.
Grottick AJ, Fletcher PJ, Higgins GA (2000) Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183-1191.
Grottick AJ, Corrigall WA, Higgins GA (2001) Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology (Berl) 157:292-298.
Gurevich I, Englander MT, Adlersberg M, et al (2002) Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 22:10529-10532.
Halford JC, Wanninayake SC, Blundell JE (1998) Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 61:159-168.
Halford JC, Harrold JA, Boyland EJ, et al (2007) Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 67:27-55.
Harrison AA, Everitt BJ, Robbins TW (1997) Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dop-aminergic mechanisms. Psychopharmacology (Berl) 133:329-342.
Hayashi A, Suzuki M, Sasamata M, et al (2005) Agonist diversity in 5-HT2C receptor-mediated weight control in rats. Psychopharmacology (Berl) 178:241-249.
Hayes DJ, Clements R, Greenshaw AJ (2008) Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. Psych2oCpharmacology (Berl) 203:579-588.
Hayes DJ, Mosher TM, Greenshaw AJ (2009) Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Behav Brain Res 197:323-330.
Hewitt KN, Lee MD, Dourish CT, et al (2002) Serotonin 2C receptor agonists and the behavioral satiety sequence in mice. Pharmacol Biochem Behav 71:691-700.
Higgins GA, Fletcher PJ (2003) Serotonin and drug reward:focus on 5-HT2C receptors. Eur J Pharmacol 480:151-162.
Higgins GA, Enderlin M, Haman M, et al (2003) The 5-HT2A receptor antagonist M100,907 attenuates motor and "impulsive-type" behaviors produced by NMDA receptor antagonism. Psychopharmacology (Berl) 170:309-319.
Hitsman B, Pingitore R, Spring B, et al (1999) Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 67:547-554.
Hoebel BG, Hernandez L, McClelland RC, et al (1988) Dexfenfluramine and feeding reward. Clin Neuropharmacol 11(suppl 1):S72-S85.
Hollander E, Rosen J (2000) Impulsivity. J Psychopharmacol 14:S39-S44.
Howell LL, Byrd LD (1995) Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275:1551-1559.
Hoyer D (1988) Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci 9:89-94.
Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13-23.
Hoyer D, Clarke DE, Fozard JR, et al (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157-203.
Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554.
Hutson PH, Barton CL, Jay M, et al (2000) Activation of mesolimbic dopamine function by phen-cyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioral studies. Neuropharmacology 39:2318-2328.
Invernizzi RW, Pierucci M, Calcagno E, et al (2007) Selective activation of 5-HT2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 144:1523-1535.
Ji SP, Zhang Y, Van Cleemput J, et al (2006) Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med 12:324-329.
Jones BJ, Blackburn TP (2002) The medical benefit of 5-HT research. Pharmacol Biochem Behav 71:555-568.
Kawahara Y, Grimberg A, Teegarden S, et al (2008) Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci 28:12834-12844.
Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56.
Kennett GA, Curzon G (1988) Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) 96:93-100.
Lam DD, Przydzial MJ, Ridley SH, et al (2008) Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149:1323-1328.
Laviolette SR, Nader K, van der Kooy D (2002) Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 129:17-29.
Le AD, Funk D, Harding S, et al (2008) Intra-median raphe nucleus (MRN) infusions of musci-mol, a GABA-A receptor agonist, reinstate alcohol seeking in rats: role of impulsivity and reward. Psychopharmacology (Berl) 195:605-615.
Leander JD (1987) Fluoxetine suppresses palatability-induced ingestion. Psychopharmacology (Berl) 91:285-287.
Lee B, Tiefenbacher S, Platt DM, et al (2004) Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 29:686-693.
Lee MD, Somerville EM, Kennett GA, et al (2004) Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice. Psychopharmacology (Berl) 176:392-49.
Leggio GM, Cathala A, Moison D, et al (2009) Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens. Neuropharmacology 56:507-513.
Leibowitz SF, Alexander JT (1998) Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44:851-864.
Liu S, Cunningham KA (2006) Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity. Drug Alcohol Depend 81:275-282.
Liu S, Bubar MJ, Lanfranco MF, et al (2007) Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 146:1677-1688.
Loh EA, Roberts DC (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berl) 101:262-266.
Lopez-Alonso VE, Mancilla-Diaz JM, Rito-Domingo M, et al (2007) The effects of 5-HT1A and 5-HT2C receptor agonists on behavioral satiety sequence in rats. Neurosci Lett 416:285-288.
Lyness WH, Friedle NM, Moore KE (1980) Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol Biochem Behav 12:937-941.
Marazziti D, Rossi A, Giannaccini G, et al (1999) Distribution and characterization of [3H]mesulergine binding in human brain postmortem. Eur Neuropsychopharmacol 10:21-26.
Markou A (2008) Review. Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci 363:3159-3168.
Maurel S, Schreiber R, De Vry J (1998) Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat. Behav Pharmacol 9:337-343.
Maurel S, De Vry J, Schreiber R (1999) 5-HT receptor ligands differentially affect operant oral self- administration of ethanol in the rat. Eur J Pharmacol 370:217-223.
Maurel S, De Vry J, De Beun R, et al (1999) 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats. Pharmacol Biochem Behav 62:89-96.
McCreary AC, Cunningham KA (1999) Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology 20:556-564.
McMahon LR, Cunningham KA (2001) Role of 5-HT2A and 5-HT2B/2C receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors. Neuropsychopharmacology 24:319-329.
McMahon LR, Filip M, Cunningham KA (2001) Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Neurosci 21:7781-7787.
Mengod G, Pompeiano M, Martinez-Mir MI, et al (1990) Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524:139-143.
Millan MJ, Marin P, Bockaert J, et al (2008) Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci 29:454-464.
Mitchell SH (2004) Measuring impulsivity and modeling its association with cigarette smoking. Behav Cogn Neurosci Rev 3:261-275.
Moeller FG, Barratt ES, Dougherty DM, et al (2001) Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783-1793.
Naranjo CA, Knoke DM (2001) The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. J Clin Psychiatry 62(suppl 20):18-25.
Naranjo CA, Poulos CX, Bremner KE, et al (1992) Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 51:729-739.
Navailles S, De Deurwaerdere P, Porras G, et al (2004) In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29:319-326.
Navailles S, Moison D, Cunningham KA, et al (2008) Differential regulation of the mesoaccum-bens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 33:237-246.
Navarra R, Comery TA, Graf R, et al (2008) The 5-HT2C receptor agonist WAY 163909 decreases impulsivity in the 5-choice serial reaction time test. Behav Brain Res 188:412-415.
Neill JC, Cooper SJ (1989) Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology (Berl) 97:213-218.
Neisewander JL, Acosta JI (2007) Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 18:791-800.
Niaura R, Spring B, Borrelli B, et al (2002) Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychol 70:887-896.
Nilsson BM (2006) 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents. J Med Chem 49:4023-4034.
Niswender CM, Herrick-Davis K, Dilley GE, et al (2001) RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24:478-491.
Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230.
Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539-546.
Peltier R, Schenk S (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology (Berl) 110:390-394.
Perkins KA, Lerman C, Coddington SB, et al (2008) Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl) 200:529-544.
Perry JL, Carroll ME (2008) The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 200:1-26.
Perry JL, Larson EB, German JP, et al (2005) Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 178:193-201.
Pettit HO, Ettenberg A, Bloom FE, et al (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine butnot heroinself-administration in rats.Psychopharmacology (Berl) 84:167-173.
Pierucci M, Di Matteo V, Esposito E (2004) Stimulation of serotonin2C receptors blocks the hyper-activation of midbrain dopamine neurons induced by nicotine administration. J Pharmacol Exp Ther 309:109-118.
Porras G, Di Matteo V, Fracasso C, et al (2002) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311-324.
Porrino LJ, Ritz MC, Goodman NL, et al (1989) Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 45:1529-1535.
Pozzi L, Acconcia S, Ceglia I, et al (2002) Stimulation of 5-hydroxytryptamine (5-HT2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J Neurochem 82:93-100.
Prisco S, Pagannone S, Esposito E (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther 271:83-90.
Quarta D, Naylor CG, Stolerman IP (2007) The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination. Psychopharmacology (Berl) 193:391-402.
Redgrave P (1978) Modulation of intracranial self-stimulation behavior by local perfusions of dopamine, noradrenaline and serotonin within the caudate nucleus and nucleus accumbens. Brain Res 155:277-295.
Remington G (2008) Alterations of dopamine and serotonin transmission in schizophrenia. Prog Brain Res 172:117-140.
Richardson NR, Roberts DC (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci 49:833-840.
Robbins TW (2002) The 5-choice serial reaction time task: behavioral pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362-380.
Roberts DC, Koob GF, Klonoff P, et al (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781-787.
Robinson ES, Dalley JW, Theobald DE, et al (2008) Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology 33:2398-2406.
Rocha BA, Goulding EH, O'Dell LE, et al (2002) Enhanced locomotor, reinforcing, and neuro-chemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 22:10039-10045.
Rosenzweig-Lipson S, Zhang J, Mazandarani H, et al (2006) Antiobesity-like effects of the 5-HT2C receptor agonist WAY 161503. Brain Res 1073-1074:240-251.
Rothman RB, Baumann MH, Savage JE, et al (2000) Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other sero-tonergic medications. Circulation 102:2836-2841.
Rowland NE, Robertson K, Lo J, et al (2001) Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats. Psychopharmacology (Berl) 156:108-114. 1B/2C
Schmidt HD, Anderson SM, Famous KR, et al (2005) Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol 526:65-76.
Schreiber R, De Vry J (2002) Role of 5-HT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the rat. Prog Neuropsychopharmacol Biol Psychiatry 26:441-449.
Schwartz DH, McClane S, Hernandez L, et al (1989) Feeding increases extracellular serotonin in the lateral hypothalamus of the rat as measured by microdialysis. Brain Res 479:349-354.
See RE (2005) Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 526:140-146.
Sesack SR, Deutch AY, Roth RH, et al (1989) Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213-242.
Sesack SR, Carr DB, Omelchenko N, et al (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann N Y Acad Sci 1003:36-52.
Shaham Y, Shalev U, Lu L, et al (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168:3-20.
Shepard JD, Bossert JM, Liu SY, et al (2004) The anxiogenic drug yohimbine reinstates metham-phetamine seeking in a rat model of drug relapse. Biol Psychiatry 55:1082-1089.
Smith BM, Smith JM, Tsai JH, et al (2008) Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity. J Med Chem 51:305-313.
Smith SR, Prosser WA, Donahue DJ, et al (2009) Lorcaserin (APD356), a selective 5-HT2C agonist, reduces body weight in obese men and women. Obesity (Silver Spring) 17:494-503.
Somerville EM, Horwood JM, Lee MD, et al (2007) 5-HT2C receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice. Eur J Neurosci 25:3115-3124.
Soubrie P (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behavioral and Brain Sciences 9:319-364.
Spyraki C, Fibiger HC, Phillips AG (1982) Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253:195-203.
Tecott LH, Sun LM, Akana SF, et al (1995) Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374:542-546.
Thomsen WJ, Grottick AJ, Menzaghi F, et al (2008) Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325:577-587.
Thomsen M, Hall FS, Uhl GR, et al (2009) Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 29:1087-1092.
Tomkins DM, Joharchi N, Tampakeras M, et al (2002) An investigation of the role of 5-HT2C receptors in modifying ethanol self-administration behavior. Pharmacol Biochem Behav 71:735-744.
Trinko R, Sears RM, Guarnieri DJ, et al (2007) Neural mechanisms underlying obesity and drug addiction. Physiol Behav 91:499-505.
van der Kooy D, Fibiger HC, Phillips AG (1977) Monoamine involvement in hippocampal self-stimulation. Brain Res 136:119-130.
van Ree JM, Gerrits MA, Vanderschuren LJ (1999) Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 51:341-396.
VanderVeen JW, Cohen LM, Cukrowicz KC, et al (2008) The role of impulsivity on smoking maintenance. Nicotine Tob Res 10:1397-1404.
Vickers SP, Clifton PG, Dourish CT, et al (1999) Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice. Psychopharmacology (Berl) 143:309-314.
Vickers SP, Dourish CT, Kennett GA (2001) Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology 41:200-209.
Volkow ND, Wise RA (2005) How can drug addiction help us understand obesity? Nat Neurosci 8:555-560.
Walsh SL, Cunningham KA (1997) Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology (Berl) 130:41-58.
Ward SJ, Lefever TW, Jackson C, et al (2008) Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharmacol Exp Ther 325:567-576.
Werry TD, Loiacono R, Sexton PM, et al (2008) RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther 119:7-23.
Willins DL, Meltzer HY (1998) Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res 781:291-299.
Winstanley CA, Theobald DE, Dalley JW, et al (2004) 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity:interactions with global 5-HT depletion. Psychopharmacology (Berl) 176:376-385.
Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240.
Wogar MA, Bradshaw CM, Szabadi E (1992) Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxytryptaminergic pathways. Psychopharmacology (Berl) 107:373-378.
Zaniewska M, McCreary AC, Przegalinski E, et al (2007) Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 571:156-165.
Zaniewska M, McCreary AC, Filip M (2009) Interactions of serotonin (5-HT)(2) receptor-targeting ligands and nicotine: Locomotor activity studies in rats. Synapse 63:653-661.
Was this article helpful?
Being addicted to drugs is a complicated matter condition that's been specified as a disorder that evidences in the obsessional thinking about and utilization of drugs. It's a matter that might continue to get worse and become disastrous and deadly if left untreated.